CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
vascular occlusion test using Pediatric SomaSensor for INVOS 5100Cother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02287753
NCT02287753N/ACompleted

Relationship Between Parameters of Vascular Occlusion Test Using Near Infrared Spectroscopy and Clinical Parameters & Outcomes in Pediatric Cardiac Surgery

Seoul National University Hospital·interventional·Posted Nov 11, 2014·Updated Apr 20, 2017

In Brief

A clinical study evaluating vascular occlusion test using Pediatric SomaSensor for INVOS 5100C for Congenital Heart Disease. Completed, enrolled 130 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the ability of vascular occlusion test (VOT) during cardiac surgery to predict postoperative outcomes in pediatric patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 11, 2014
Enrollment StartNov 1, 2013
Primary CompletionDec 1, 2016
TodayJul 1, 2026
Enrollment to primary: 3.1 yearsPosted 11.6 years ago

Interventions

vascular occlusion test using Pediatric SomaSensor for INVOS 5100Cother

Pediatric SomaSensor for INVOS 5100C is attached at calf muscle and non-invasive blood pressure cuff is applied to ipsilateral thigh. VOT is performed as: after baseline oxygen saturation value is recorded, cuff pressure is rapidly increased to 30 mmHg over than systolic blood pressure. After 3 minutes of ischemic time, cuff pressure is rapidly decreased. It is performed at 3 time periods : before start of operation, during cardiopulmonary bypass, and after weaning from cardiopulmonary bypass.